The title compounds were synthesized and characterized by IR, 1 H NMR, 13 C NMR and HRMS data. Their antimicrobial activities against bacterial strains Escherichia coli and fungal strains Aspergillus niger were evaluated.
Introduction
3,4-Dihydropyrimidin-2(1H)-ones have attracted considerable attention due their wide range of biological activities, including antitumor [1] , antioxidative [2] , antibacterial [3] , antifungal [4] , anti-inflammatory [5] and antihypertensive properties [6] . They have also been identified as calcium channel modulators [7] , A 2B adenosine receptor antagonists [8] , HIV-1 replication inhibitors [9] and human DNA ligase 1 inhibitors [10] . Hydrazones also exhibit a wide range of diverse biological activities [11] [12] [13] [14] [15] [16] [17] . In view of the biological significance of 3,4-dihydropyrimidin-2(1H)-ones and hydrazones, we designed and synthesized a series of novel 3,4-dihydropyrimidin-2(1H)-one derivatives bearing a hydrazone moiety and evaluated their antimicrobial activities against bacterial strains Escherichia coli and fungal strains Aspergillus niger.
Results and discussion
The preparation of target compounds 3a-r is shown in Scheme 1. First, 5-methoxycarbonyl-4-[(4-methoxycarbonyl)phenyl]-6-methyl-3,4-dihydropyrimidin-2(1H)-one (1a) and its 5-ethoxycarbonyl analog 1b were synthesized by three-component condensation reaction of ethyl acetoacetate or methyl acetoacetate, urea and 4-methoxycarbonylbenzaldehyde in ethanol in the presence of p-toluenesulfonic acid as catalyst. Then, products 1a and 1b were allowed to react with hydrazine in ethanol under reflux to afford the corresponding hydrazine derivatives 2a and 2b. Apparently for steric reasons, the methoxycarbonyl or ethoxycarbonyl group (COR 1 ) at the dihydropyrimidinone ring of 1a and 1b did not react with hydrazine to give the hypothetical compound 4. In the final step, the target compounds 3a-r were prepared by a condensation reaction of 2a or 2b with different aromatic aldehydes in ethanol in the presence of acetic acid. Structures of all synthetic compounds were confirmed by analysis of IR, 1 H NMR, 13 C NMR and HRMS data. All synthesized compounds were evaluated for their antimicrobial activities against bacterial strains E. coli and fungal strains A. niger. All compounds show moderate inhibitory effect against the bacterial and fungal strains. Most of them show better inhibitory activity than the starting materials 1a and 1b. Compounds 3b, 3f, 3i, 3j and 3l demonstrate good antibacterial activity which is nearly equal to that of the reference antibiotic ciprofloxacin. Compound 3a is an excellent antifungal agent, the activity of which is comparable to that of the reference antibiotic fluconazole.
Conclusions
New 3,4-dihydropyrimidin-2(1H)-ones containing a hydrazone moiety were designed, synthesized and evaluated for antimicrobial activities against E. coli and A. niger. All compounds show moderate inhibitory activities against E. coli and A. niger. Compounds 3b, 3f, 3i, 3j and 3l show good antibacterial activity and compound 3a is an excellent antifungal agent.
Experimental
Reagents were purchased from commercial sources and used without further purification. Melting points were determined on a Yanaco micro melting point apparatus and are uncorrected. Infrared spectra were recorded on a Nicolet 6700 infrared spectrometer. NMR spectra were recorded at 400 MHz ( 1 H) and 100 MHz ( 13 C) on a Bruker spectrometer using TMS as an internal standard and DMSO-d 6 as solvent. High resolution mass spectra (HRMS) were obtained on a Thermo Scientific spectrometer using electrospray ionization (ESI).
General procedure for the preparation of 1a and 1b
These compounds were prepared using the following modification of a published procedure [18] . A mixture of ethyl acetoacetate or methyl acetoacetate (20 mmol), urea (20 mmol), 4-methoxycarbonylbenzaldehyde (20 mmol) and p-toluenesulfonic acid (10 mol%) in ethanol (100 mL) was stirred and heated under reflux. After cooling, the resulting solid product was filtered and crystallized from ethanol to afford pure compound 1a,b. 
4-[4-(Methoxycarbonyl

General procedure for the preparation of 2a and 2b
A solution of 1a or 1b (10 mmol) and hydrazine hydrate (80%, 50 mmol) in absolute ethanol (20 mL) was heated under reflux for 12 h. Upon cooling, the resultant precipitate was filtered and crystalized from ethanol to give the hydrazide derivative 2a,b. 
4-[4-(Hydrazinocarbonyl
5-Ethoxycarbonyl-4-[4-(hydrazinocarbonyl)phenyl]-6-methyl-3,4-dihydropyrimidin-2(1H)-one (2b) White
General procedure for the preparation of 3a-r
A mixture of 2a or 2b (2 mmol) and aromatic aldehyde (2.2 mmol) in ethanol/DMF was heated under reflux for 5 h in the presence of catalytic amount of glacial acetic acid, then cooled and poured into ice water. The resultant precipitate was filtered and crystalized from ethanol/DMF to obtain the target compound 3a-r. 1, 163.5, 152.5, 149.6, 148.9, 143.0, 135.5, 134.3, 132.7, 131.2, 129.9 149.3, 148.8, 148.2, 134.8, 133.0, 130.5, 129.3, 128.4, 127.5, 126.8 -4-[4-(2-(4-methoxybenzylidene)hydrazinocarbonyl)phenyl]-6-methyl-3,4-dihydropyrimidin-2(1H) 
4-[4-(2-Benzylidenehydrazinocarbonyl
4-[4-(2-(4-Methoxybenzylidene)hydrazinocarbonyl)phenyl]-5-methoxycarbonyl-6-methyl-3,4-dihydropyrimidin-2(1H)-one (3b) White
4-[4-(2-(4-N,N-Dimethylaminophenylbenzylidene)hydrazinocarbonyl)phenyl]-5-methoxycarbonyl-6-methyl-3,4-dihydropyrimidin-2(1H)-one (3c) Yellow
), 2.28 (s, 3H, CH 3 ); 13 C NMR: δ 166.2, 163.2, 157.9, 152.5, 149.6
4-[4-(2-(4-Chlorobenzylidene)hydrazinocarbonyl)phenyl]-5-methoxycarbonyl-6-methyl-3,4-dihydropyrimidin-2(1H)-one (3f) White
4-[4-(2-(4-Bromobenzylidene)hydrazinocarbonyl)phenyl]-5-methoxycarbonyl-6-methyl-3,4-dihydropyrimidin-2(1H)-one (3g) White
5-Methoxycarbonyl-6-methyl-4-[4-(2-(3-nitrobenzylidene) hydrazinocarbonyl)phenyl]-3,4-dihydropyrimidin-2(1H)-one (3h) White
5-Ethoxycarbonyl
5-Ethoxycarbonyl-4-[4-(2-(4-N,N-dimethylaminophenylbenzylidene)hydrazinocarbonyl)phenyl]-6-methyl-3,4-dihydropyrimidin-2(1H)-one (3l) Yellow
Antimicrobial activity
The antimicrobial activities were determined against bacterial strain E. coli and fungal strain A. niger by the standardized disk diffusion method [19] at 50 μg/mL concentration in DMSO. The antimicrobial activity was determined by measuring the diameter of inhibition zone. Ciprofloxacin and fluconazole were used as standard drugs against bacterial and fungal strains, respectively, at 50 μg/mL concentration.
